Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATN-224 plus letrozole vs letrozole in recurrent hormone receptor-positive breast cancer
2006-004149-40Phase 2Terminated
- Sponsor
- Cancer Research UK
- Start
- Aug 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in breast cancer comparing ATN-224 plus letrozole with Letrozole alone (2 arms). Primary endpoint: Progression-free survival. Started Aug 2011; status: terminated.
02
Drugs
tetrathiomolybdateletrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2006-004149-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004149-40.